Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis.

Black RJ, Richards B, Lester S, Buchbinder R, Barrett C, Lassere M, March L, Hill CL.

Semin Arthritis Rheum. 2019 Jun 10. pii: S0049-0172(18)30582-1. doi: 10.1016/j.semarthrit.2019.06.003. [Epub ahead of print]

PMID:
31280936
2.

The OMERACT Emerging Leaders Program: The Good, the Bad and the Future.

Flurey CA, Tugwell PS, Black RJ, Halls S, Page MJ, Robson JC, Sahbudin I, Siddle HJ, Sinnathurai P, Stok KS, Richards B.

J Rheumatol. 2019 Mar 1. pii: jrheum.181126. doi: 10.3899/jrheum.181126. [Epub ahead of print]

PMID:
30824659
3.

Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group.

Cheah JTL, Black RJ, Robson JC, Navarro-Millán IY, Young SR, Richards P, Beard S, Simon LS, Goodman SM, Mackie SL, Hill CL.

J Rheumatol. 2019 Jan 15. pii: jrheum.181082. doi: 10.3899/jrheum.181082. [Epub ahead of print]

PMID:
30647165
4.

Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.

Black RJ, Lester S, Buchbinder R, Barrett C, Lassere M, March L, Whittle S, Hill CL.

Arthritis Res Ther. 2017 Nov 15;19(1):253. doi: 10.1186/s13075-017-1461-3.

5.

A Survey of Glucocorticoid Adverse Effects and Benefits in Rheumatic Diseases: The Patient Perspective.

Black RJ, Goodman SM, Ruediger C, Lester S, Mackie SL, Hill CL.

J Clin Rheumatol. 2017 Dec;23(8):416-420. doi: 10.1097/RHU.0000000000000585.

6.

The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.

Mackie SL, Twohig H, Neill LM, Harrison E, Shea B, Black RJ, Kermani TA, Merkel PA, Mallen CD, Buttgereit F, Mukhtyar C, Simon LS, Hill CL; OMERACT PMR Working Group.

J Rheumatol. 2017 Oct;44(10):1515-1521. doi: 10.3899/jrheum.161109. Epub 2017 Aug 1.

7.

A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group.

Black RJ, Robson JC, Goodman SM, Hoon E, Lai LYH, Simon LS, Harrison E, Neill L, Richards P, Nelsen LM, Nebesky JM, Mackie SL, Hill CL.

J Rheumatol. 2017 Nov;44(11):1754-1758. doi: 10.3899/jrheum.161083. Epub 2017 Apr 1.

8.

Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis.

Hill CL, Black RJ, Nossent JC, Ruediger C, Nguyen L, Ninan JV, Lester S.

Semin Arthritis Rheum. 2017 Feb;46(4):513-519. doi: 10.1016/j.semarthrit.2016.08.015. Epub 2016 Aug 25. Review.

PMID:
28040246
9.

The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Black RJ, Hill CL, Lester S, Dixon WG.

PLoS One. 2016 Nov 15;11(11):e0166468. doi: 10.1371/journal.pone.0166468. eCollection 2016. Review.

10.

Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study.

Black RJ, Joseph RM, Brown B, Movahedi M, Lunt M, Dixon WG.

Arthritis Res Ther. 2015 Dec 24;17:375. doi: 10.1186/s13075-015-0895-8.

11.

Design of an Optically Controlled MR-Compatible Active Needle.

Ryu SC, Quek ZF, Koh JS, Renaud P, Black RJ, Moslehi B, Daniel BL, Cho KJ, Cutkosky MR.

IEEE Trans Robot. 2015 Feb;31(1):1-11.

12.

Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay.

Bunch KJ, Vincent TJ, Black RJ, Pearce MS, McNally RJ, McKinney PA, Parker L, Craft AW, Murphy MF.

Br J Cancer. 2014 Oct 28;111(9):1814-23. doi: 10.1038/bjc.2014.357. Epub 2014 Jul 22.

13.

Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis.

Black RJ, Spargo L, Schultz C, Chatterton B, Cleland L, Lester S, Hill CL, Proudman SM.

Arthritis Care Res (Hoboken). 2014 Apr;66(4):515-22. doi: 10.1002/acr.22199.

14.

Towards a quantitative understanding of palladium metal scavenger performance: an electronic structure calculation approach.

Mondal B, Wilkes RD, Percy JM, Tuttle T, Black RJ, North C.

Dalton Trans. 2014 Jan 14;43(2):469-78. doi: 10.1039/c3dt52282b. Epub 2013 Oct 11.

15.

Risk of cancer following primary total hip replacement or primary resurfacing arthroplasty of the hip: a retrospective cohort study in Scotland.

Brewster DH, Stockton DL, Reekie A, Ashcroft GP, Howie CR, Porter DE, Black RJ.

Br J Cancer. 2013 May 14;108(9):1883-90. doi: 10.1038/bjc.2013.129. Epub 2013 Apr 2.

16.

MR-compatible biopsy needle with enhanced tip force sensing.

Elayaperumal S, Bae JH, Christensen D, Cutkosky MR, Daniel BL, Costa JM, Black RJ, Faridian F, Moslehi B.

Joint Eurohaptics Conf Symp Haptic Interfaces Virtual Environ Teleoper Syst. 2013 Apr;2013:109-114.

17.

The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study.

Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, Fraser CG, Steele RJ.

Br J Cancer. 2012 Jul 10;107(2):255-9. doi: 10.1038/bjc.2012.277. Epub 2012 Jun 26.

18.

An Optical Actuation System and Curvature Sensor for a MR-compatible Active Needle.

Ryu SC, Quek ZF, Renaud P, Black RJ, Daniel BL, Cutkosky MR.

IEEE Int Conf Robot Autom. 2012 May;2012:1589-1594.

19.

Feasibility Study of an Optically Actuated MR-compatible Active Needle.

Ryu SC, Renaud P, Black RJ, Daniel BL, Cutkosky MR.

Rep U S. 2011 Sep;2011:2564-2569.

20.

Studies on transannulation reactions across a nine-membered ring: the synthesis of natural product-like structures.

Iqbal M, Black RJ, Winn J, Reeder AT, Blake AJ, Clarke PA.

Org Biomol Chem. 2011 Jul 21;9(14):5062-78. doi: 10.1039/c1ob05448a. Epub 2011 May 20.

PMID:
21597625
21.

Real-Time Estimation of 3-D Needle Shape and Deflection for MRI-Guided Interventions.

Park YL, Elayaperumal S, Daniel B, Ryu SC, Shin M, Savall J, Black RJ, Moslehi B, Cutkosky MR.

IEEE ASME Trans Mechatron. 2010 Dec;15(6):906-915.

22.

UK cancer survival statistics. Survival is multifactorial.

Brewster DH, Black RJ.

BMJ. 2010 Sep 22;341:c5133. doi: 10.1136/bmj.c5133. No abstract available.

PMID:
20861103
23.

Scalpel safety in the operative setting: a systematic review.

Watt AM, Patkin M, Sinnott MJ, Black RJ, Maddern GJ.

Surgery. 2010 Jan;147(1):98-106. doi: 10.1016/j.surg.2009.08.001. Epub 2009 Oct 13. Review.

PMID:
19828169
24.

Scalpel injuries in the operating theatre.

Watt AM, Patkin M, Sinnott MJ, Black RJ, Maddern GJ.

BMJ. 2008 May 10;336(7652):1031. doi: 10.1136/bmj.39548.418009.80. No abstract available.

25.

Ototoxic ear drops with grommet and tympanic membrane perforations: a position statement.

Black RJ, Cousins VC, Chapman P, Becvarovski Z, Coates HL, O'Leary SJ, Perry CF, Williams BJ.

Med J Aust. 2007 Jun 4;186(11):605-6. No abstract available. Erratum in: Med J Aust. 2007 Jul 2;187(1):62.

PMID:
17547553
26.

Randomized comparison of two anti-emetic strategies in high-risk patients undergoing day-case gynaecological surgery.

White H, Black RJ, Jones M, Mar Fan GC.

Br J Anaesth. 2007 Apr;98(4):470-6. Epub 2007 Feb 22.

27.
28.

Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.

Black RJ, Gavin AT.

Br J Dermatol. 2006 Mar;154(3):566-7. No abstract available.

PMID:
16445801
29.

Isolated acetabular osteoporosis in TOH in pregnancy: a case report.

Debnath UK, Kishore R, Black RJ.

South Med J. 2005 Nov;98(11):1146-8.

PMID:
16351039
30.
31.

Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, Cheever L, Johnson M, Paxton LA, Onorato IM, Greenberg AE; U.S. Department of Health and Human Services.

MMWR Recomm Rep. 2005 Jan 21;54(RR-2):1-20.

32.

Impact of a cancer registry-based genealogy service to support clinical genetics services.

Brewster DH, Fordyce A, Black RJ; Scottish Clinical Geneticists.

Fam Cancer. 2004;3(2):139-41.

PMID:
15340265
33.
34.

Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.

Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ; Scottish Cancer Therapy Network.

J Epidemiol Community Health. 2001 May;55(5):308-15.

35.

Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies.

Brewster DH, Thomson CS, Hole DJ, Black RJ, Stroner PL, Gillis CR.

BMJ. 2001 Apr 7;322(7290):830-1. No abstract available.

36.

Risk of malignancy among patients with rheumatic conditions.

Thomas E, Brewster DH, Black RJ, Macfarlane GJ.

Int J Cancer. 2000 Nov 1;88(3):497-502.

37.

Training in otolaryngology--head and neck surgery in Australia and New Zealand.

Black RJ.

J Laryngol Otol. 2000 Jul;114(7):494-6. No abstract available.

PMID:
10992927
38.

Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland.

Brewster DH, Fraser LA, McKinney PA, Black RJ.

Br J Cancer. 2000 Aug;83(3):387-90.

39.

Rising incidence of prostate cancer in Scotland: increased risk or increased detection?

Brewster DH, Fraser LA, Harris V, Black RJ.

BJU Int. 2000 Mar;85(4):463-72; discussion 472-3.

40.

Incidence of non-Hodgkin's lymphoma in children between 1970 and 1990 in nine European countries.

Weidmann C, Black RJ, Masuyer E, Parkin DM.

Eur J Cancer. 1999 Aug;35(8):1235-7.

PMID:
10615235
41.

Cancer registry data based estimation of regional cancer incidence: application to breast and colorectal cancer in French administrative regions.

Colonna M, Grosclaude P, Faivre J, Revzani A, Arveux P, Chaplain G, Tretarre B, Launoy G, Lesec'h JM, Raverdy N, Schaffer P, Buémi A, Ménégoz F, Black RJ.

J Epidemiol Community Health. 1999 Sep;53(9):558-64.

42.
43.

Epidemiology of Kaposi's sarcoma in Scotland, 1976-1996.

Brewster DH, Harris V, Black RJ, Goldberg DJ.

Br J Cancer. 1999 Apr;79(11-12):1938-42.

44.

An overview of cancer survival in developing countries.

Sankaranarayanan R, Black RJ, Swaminathan R, Parkin DM.

IARC Sci Publ. 1998;(145):135-73. No abstract available.

PMID:
10194635
45.

Database on cancer survival from developing countries.

Swaminathan R, Black RJ, Sankaranarayanan R.

IARC Sci Publ. 1998;(145):19-25. No abstract available.

PMID:
10194624
46.

Interpretation of population-based cancer survival data.

Black RJ, Sankaranarayanan R, Parkin DM.

IARC Sci Publ. 1998;(145):13-7. Review. No abstract available.

PMID:
10194623
47.

World standard cancer patient populations: a resource for comparative analysis of survival data.

Black RJ, Bashir SA.

IARC Sci Publ. 1998;(145):9-11. No abstract available.

PMID:
10194622
48.

Statistical methods for the analysis of cancer survival data.

Black RJ, Swaminathan R.

IARC Sci Publ. 1998;(145):3-7. Review. No abstract available.

PMID:
10194621
49.

Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation.

Brewster DH, Black RJ.

J Public Health Med. 1998 Jun;20(2):236-8. No abstract available.

PMID:
9675748
50.

Cancer incidence and mortality in France in 1975-95.

Ménégoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buémi A, Carli PM, Chapelain G, Faivre J, Gignoux M, Grosclaude P, Mace-Lesec'h J, Raverdy N, Schaffer P.

Eur J Cancer Prev. 1997 Oct;6(5):442-66.

PMID:
9466116

Supplemental Content

Loading ...
Support Center